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Abstract 27 
Insulin is a key hormone controlling metabolic homeostasis. Loss or dysfunction of 28 
pancreatic β-cells lead to the release of insufficient insulin to cover the organism needs, 29 
promoting diabetes development. Since dietary nutrients influence the activity of β-cells, 30 
their inadequate intake, absorption and/or utilization can be detrimental. This review will 31 
highlight the physiological and pathological effects of nutrients on insulin secretion and 32 
discuss the underlying mechanisms. Glucose uptake and metabolism in β-cells trigger 33 
insulin secretion. This effect of glucose is potentiated by amino acids and fatty acids, as 34 
well as by entero-endocrine hormones and neuropeptides released by the digestive tract in 35 
response to nutrients. Glucose controls also basal and compensatory β-cell proliferation 36 
and, along with fatty acids, regulates insulin biosynthesis. If in the short term nutrients 37 
promote β-cell activities, chronic exposure to nutrients can be detrimental to β-cells and 38 
causes reduced insulin transcription, increased basal secretion and impaired insulin 39 
release in response to stimulatory glucose concentrations, with a consequent increase in 40 
diabetes risk. Likewise, suboptimal early-life nutrition (e.g. parental high-fat or low-41 
protein diet) causes altered β-cell mass and function in adulthood. The mechanisms 42 
mediating nutrient-induced β-cell dysfunction include transcriptional, post-transcriptional 43 
and translational modifications of genes involved in insulin biosynthesis and secretion, 44 
carbohydrate and lipid metabolism, cell differentiation, proliferation and survival. Altered 45 
expression of these genes is partly caused by changes in non-coding RNA transcripts 46 
induced by unbalanced nutrient uptake. A better understanding of the mechanisms 47 
leading to β-cell dysfunction will be critical to improve treatment and find a cure for 48 
diabetes. 49 
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Introduction 50 
Appropriate nutritional intake and utilization are essential for proper functioning of our 51 
organism. Indeed, deficiency or excess of certain nutrients are at the origin of many 52 
diseases, including diabetes mellitus. Nutrients can be subdivided in two main categories, 53 
micronutrients and macronutrients. Micronutrients include vitamins and minerals and are 54 
essential for the function of cells and organ systems (1, 2). Macronutrients include 55 
carbohydrates, amino acids and fat, and serve as energy sources and structural 56 
components of the cells (1). The fate of the ingested macronutrients is determined by an 57 
integrated network of hormonal and neural signals which, according to the metabolic 58 
status of the organism, orchestrate the immediate use of the ingested molecules, their 59 
biochemical transformation or their long-term storage (3). An in depth knowledge of the 60 
processes regulating nutrient uptake and utilization is essential for understanding the 61 
mechanisms responsible of metabolic homeostasis and for elucidating the causes of 62 
metabolic disorders such as diabetes mellitus.  63 
Sensory contact with food and stimulation of the oral cavity elicit salivation, 64 
gastric acid production and pancreatic exocrine and endocrine secretions (4, 5). These 65 
early responses referred to as cephalic phase serve to prepare the digestive tract for 66 
digestion, absorption and utilization of nutrients and are followed by a gastro-intestinal 67 
phase when food reaches the stomach (4-6). During this second phase, the gastro-68 
duodeno-jejunal mucosa and the enteric nervous system release numerous peptides, 69 
entero-hormones and neurotransmitters via paracrine, endocrine and neural mechanisms 70 
that coordinate nutrient absorption and utilization to achieve metabolic homeostasis (7, 71 
8). 72 
Insulin, a peptide hormone produced by pancreatic β-cells within the islets of 73 
Langerhans is at the core of this complex regulatory network and plays an essential role 74 
in blood glucose homeostasis and in the control of body metabolism. The amount of 75 
insulin released in the circulation is precisely tuned to prevent tissue damage caused by 76 
chronic hyperglycemia and the life-threatening effects of prolonged hypoglycemia (9, 77 
10). The aim of this review will be to discuss the direct and indirect impacts of 78 
macronutrients on β-cells and to evaluate their contribution to the control of insulin 79 
secretion under physiological and pathological conditions.   80 
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81 
Pancreatic β-cells as nutrient sensors 82 
83 
Pancreatic β-cells, are highly differentiated cells that are often referred to as the “fuel 84 
sensors” because of their capacity to monitor and respond to dietary nutrients (11, 12). 85 
The task of β-cells is to detect the changes in the concentration of nutrients in the 86 
bloodstream and to release appropriate amounts of insulin to ensure prompt and efficient 87 
metabolic disposal (13). Insulin secretion in man and animals is pulsatile and follows the 88 
oscillatory metabolism of nutrients (14, 15). The β-cells are able to integrate a variety of 89 
signals elicited by nutrients in the gut, brain and in the β-cells them-selves permitting the 90 
fine-tuning of insulin release (16-18) (Figure 1).  91 
92 
Cephalic insulin release: far from anecdotic 93 
In humans and rodents there is a robust cephalic phase insulin release (CPIR) that occurs 94 
in response to sensory stimulation of the oral cavity caused by mastication, tasting or 95 
food ingestion (19, 20). Several studies in humans and rodents demonstrated that 96 
blockade of the insulin response during this phase results in poor glycemic control and 97 
reduces the immediate food intake (21). Insulin release during the pre-absorptive period 98 
is believed to contribute to the optimization of postprandial glucose homeostasis by 99 
preventing a rapid rise in plasma glucose levels and an exaggerated insulin peak. CPIR 100 
permits also to inhibit glucose production in the liver and lipolysis in adipose tissue and 101 
thus to regulate energy homeostasis (22, 23). Obese and type 2 diabetes (T2D) subjects 102 
who are insulin resistant and hyperinsulinemic display a reduced CPIR, resulting in 103 
elevation of postprandial glucose levels by about 40% (21, 24). Remarkably, mimicking 104 
CPIR by the infusion of tiny insulin amounts prior or during the first 10 min of food 105 
ingestion, had no effect on postprandial insulin or glucose levels in lean subjects but 106 
improved glucose control in obese (25) and in both, T1D (26) and T2D patients (27). 107 
These data strengthen the importance of early insulin release for maintaining postprandial 108 
glucose clearance and homeostasis and suggest that defective CPIR may contribute to 109 
perturbed glucose tolerance associated with metabolic disorders and diabetes. 110 
111 
Gastro-intestinal phase of insulin secretion 112 
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Upon arrival into the gut, the nutrients activate a regulatory signaling network between 113 
the gut and the pancreatic islets that plays a central role in metabolic homeostasis (28). 114 
This entero-insular axis involves the release of numerous hormones by entero-endocrine 115 
cells of the gastric-duodeno-jejunal mucosa exerting an insulinotropic action (29) (Table 116 
1). This so-called incretin effect is responsible for the differences observed in the amount 117 
of insulin released following oral and infused food intake (30). Although the list of 118 
gastric and gut-derived hormones and peptides is still expanding, the strongest candidates 119 
for the incretin effect are the glucose-dependent insulinotropic polypeptide (GIP) and 120 
glucagon-like peptide 1 (GLP-1) (31, 32). Recently, evidence for an entero-endocrine 121 
signal attenuating insulin secretion under fasting conditions has also been provided. 122 
Indeed, the Drosophila peptide Limostatin released from nutrient sensing-cells in the gut 123 
and its mammalian orthologue Neuromedin U were proposed to decrease insulin 124 
production by directly targeting the β-cells (33).  125 
The passage of nutrients through the gastrointestinal tract stimulates also the 126 
secretion of numerous neuropeptides (neuropeptide Y, neuromedin, opioid-like peptides 127 
(enkephalin and endorphin), galanin, vasoactive intestinal polypeptide (VIP), calcitonin 128 
gene-related peptide (CGRP), substance P, taurine, etc) and neurotransmitters 129 
(acetylcholine, norepinephrine, serotonin, GABA, ATP, nitric oxide, etc) by the enteric 130 
nervous system (34) (Table 1). These molecules can affect pancreatic secretion through 131 
the vagal nerve and contribute to the regulation of insulin release both in the early and 132 
postprandial phases (7). The activation of enteric neurons is a major component of the so-133 
called “gut-brain axis”. The complex and fascinating connections between the 134 
gastrointestinal tract and the central and peripheral nervous systems has been extensively 135 
reviewed elsewhere (35, 36) and will not be discussed further in this paper. 136 
137 
Impact of nutrients on β-cell signaling 138 
The metabolic signaling pathways elicited in β-cells by nutrients and culminating in 139 
insulin secretion are intensively investigated since decades. Because of space constrains, 140 
in this section we will only highlight the main molecular mechanisms governing the 141 
effects of macronutrients on β-cells and we refer the reader to other excellent reviews that 142 
have extensively addressed this matter (11, 12, 37). Nutrient-induced insulin secretion 143 
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from β-cells occurs through a unique signal transduction system, which differs 
considerably from that of neuromodulators or peptide hormones. Indeed, nutrients must 
be metabolized in the β-cell to cause insulin secretion (12). In contrast, other 
secretagogues, such as incretins, cytokines, neurotransmitters etc. modulate insulin 
secretion by binding to specific cell-surface receptors and by activating signaling 
cascades that involve the production of classical second messengers such as Ca
2+
 and 
cAMP (38, 39). Nutrients, such as glucose and fatty acids, have a dual effect on β-cell 
function. Acute exposure of β-cells to elevated glucose or fatty acid concentrations 
stimulates insulin secretion while prolonged exposure to these same nutrients causes 
impaired insulin secretion, characterized by excessive hormone release at low glucose 
concentrations and no further increase upon glucose rise (40, 41). Glucose enters the β- 
cells and is metabolized, resulting in an increase in the ATP/ADP ratio, closure of ATP- 
sensitive K
+
 channels and membrane depolarization. This will in turn trigger the opening 
of L-type Ca
2+
 channels, causing a rapid rise in intracellular Ca
2+
 concentration and the 
fusion of insulin-containing granules with the plasma membrane (42). Although glucose 
is unequivocally the principal factor triggering insulin release, several other macro- and 
micronutrients act synergistically with glucose to potentiate secretion. Until recently, the 
dietary monosaccharide fructose was believed to be unable to stimulate insulin secretion 
because β-cells do not express the fructose transporter GLUT5 (43, 44). However, recent 
work has provided evidence that fructose can potentiate glucose-induced insulin secretion 
by binding to the sweet taste receptors that are present both in mouse and human β-cells 
(45-47). Free fatty acids (FFA) have also the capacity to amplify insulin secretion, 
through three interdependent processes, defined as the “trident model” of β-cell signaling 
(48). Two pathways involve intracellular fatty acid metabolism, whereas the last one 
relies on the activation of a membrane-bound FFA receptor. FFA potentiation of glucose- 
induced insulin secretion is particularly effective and vital under conditions of insulin 
resistance, when β-cells are called to compensate for the increased insulin needs (49, 50). 
Although dietary proteins by themselves do not provoke a frank insulin excursion, co- 
ingested with carbohydrates they can markedly potentiate the insulin response. However, 
their impact on insulin secretion varies depending on the quality and quantity of proteins 
present in the meals (51). Diets with a low protein content induce a mild insulin secretion 174 
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whereas a high protein meal potentiates the insulinemic response. The reduced glycemic 175 
excursion in response to proteins and fat added on top of carbohydrates appear to be lost 176 
or attenuated in diabetic subjects (52). The amino acid composition will determine how 177 
insulin secretion is induced (53). The cationic amino acid L-Arginine, induces plasma 178 
membrane depolarization and triggers insulin granule exocytosis upon Ca
2+
 entry through 179 
voltage-gated channels. L-Alanine is co-transported with Na
+
 and induces cell membrane 180 
depolarization, voltage-dependent Ca
2+
channel opening and, consequently, insulin 181 
granules exocytosis. The metabolism of alanine results in increased intracellular ATP 182 
levels and activation of a signaling cascade leading to insulin exocytosis. Aspartate and 183 
glutamate are key components of the NADH shuttles, a primordial mechanism to achieve 184 
efficient glucose oxidation (53).  185 
In addition to being insulin secretagogues, nutrients regulate proliferation and 186 
survival of β-cells (54, 55) and exposure to nutrients can affect β-cell fate and 187 
characteristics. A recent study allowed the identification in larval Zebrafish of a 188 
compensatory mechanism in which β-cells promote differentiation of new endocrine 189 
precursor cells in response to overnutrition and to the resulting insufficient insulin 190 
secretory capacity (56). Similar results were found in the mature Zebrafish pancreas with 191 
the identification of active nutrient sensitive progenitors and β-cell differentiation in 192 
response to metabolic cues (57). The same authors observed also a dramatic increase in β-193 
cell proliferation in response to a high-calorie diet. Both, β-cell proliferation and 194 
differentiation were associated to the down-regulation of the Notch signaling pathway 195 
and to the activation of mTOR-dependent signaling (57). Dor and colleagues have further 196 
characterized the tight regulation of β-cell maturation and function in response to nutrient 197 
stimuli and food composition (58). Indeed, in mice the transition from the high-fat mother 198 
milk to a carbohydrate rich chow diet, enables the β-cells to acquire their glucose 199 
responsiveness and their capacity to proliferate under conditions of increased insulin 200 
demand (58). The nutritional transition occurring in this critical developmental window 201 
are therefore essential for the acquisition of an appropriate functional β-cell mass.  202 
203 
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Impact of nutrients on β-cell gene expression 204 
The pancreatic islets are highly vascularized structures and nutrients and other circulating 205 
factors impact not only on β-cell secretory functions but also on other β-cell activities 206 
such as proliferation and survival. Indeed, glucose sensing regulates both basal β-cell 207 
proliferation rate and their capacity to regenerate following injury. Dor and colleagues 208 
provided evidence that glucose-induced proliferation requires the activation of 209 
glucokinase, the enzyme that catalyzes the initial step of glucose utilization in β-cells 210 
(59). Further investigations revealed a β-cell specific regulation of the level of cyclin D2 211 
mRNA driven by glucose metabolism exerted through the activation of a Ca
2+
-dependent212 
pathway (60). 213 
However, chronic exposure to elevated concentrations of glucose and lipids is 214 
detrimental for β-cells. The excess of nutrients can lead to deterioration of β-cell function 215 
through the modification of transcriptional, post-transcriptional and translational events. 216 
Multiple independent studies that analyzed the transcriptomic profile of human or rodent 217 
diabetic islets or of islets exposed to a diabetogenic environment, identified alterations in 218 
the expression of genes associated with insulin processing and secretion (e.g., Pcsk1/2, 219 
GLP1R), lipid metabolism (e.g., Stearoyl-CoA desaturase 1 gene (SCD1), stearoyl-CoA 220 
desaturase 2 (SCD2), and fatty acid desaturase-2 (FAD)) oxidative stress (e.g., Cdkn1b, 221 
Tmem27, Pax6, Cat, Prdx4 and Txnip), cell proliferation and islet cell differentiation 222 
(e.g., Cdkn1b, Tmem27 and Pax6) (61-63). A better understanding of the role of these 223 
differentially expressed genes in obese- and diabetes-associated settings may help 224 
understanding the factors linking obesity to impaired islet-cell activity. Reduced 225 
expression of the glucose-transporters GLUT1 and GLUT2 (encoded by Slc1a1 and 226 
Slc2a2 genes, respectively) have been reported in human islets isolated from 227 
hyperglycemic T2D donors (64). In vitro investigations in an insulin-secreting β-cell line 228 
demonstrated that, in the presence of chronically elevated extracellular glucose 229 
concentrations, GLUT2 is either directly degraded at the plasma membrane or undergoes 230 
endocytosis followed by a rapid degradation (65). The glucose-dependent degradation of 231 
GLUT-2 suggests that systemic nutrient overload can directly contribute to impaired β-232 
cell glucose sensing and to the consequent loss of metabolic homeostasis. Glucose 233 
controls also the binding of several key transcription factors (e.g., MafA, NeuroD, PDX1) 234 
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to the insulin gene promoter and is thus a major physiologic modulator of insulin gene 235 
expression (66). Impaired PDX-1 and MafA binding to the insulin promoter is also 236 
observed upon prolonged exposure to the saturated fatty acid palmitate (67). Hence, both, 237 
glucose and palmitate are able to affect the binding of transcription factors that control 238 
the activity of the insulin promoter, pointing to an involvement of these regulators of 239 
gene expression in the mechanisms of glucolipotoxicity (68). 240 
Emerging evidence suggest an impact of diet-dependent epigenetic modifications 241 
in the etiology of metabolic disorders (69). Hu et al. observed an aberrant DNA 242 
methylation profile in β-cells cultured for 1 month in a medium containing high glucose 243 
and lipid concentrations. Although, DNA methylation is a key event associated with gene 244 
silencing, TCF7L2 mRNA was unexpectedly increased whereas the protein Tcf7l2 was 245 
reduced in islets under conditions of glucolipotoxicity (70). The transcription factor 246 
Tcf7l2 has been shown to regulate both β-cell proliferation and insulin secretion (71). 247 
Elevated mRNA levels of Tcf7l2 and reduced protein levels have also been observed in 248 
islets of T2D patients and in diabetic animal models (70, 72, 73), emphasizing the 249 
potential involvement of nutrient-induced gene expression changes in metabolic 250 
disturbances. Ling and colleagues analyzed the genome-wide expression profile of 251 
palmitate-treated human islets and identified 1,860 differentially expressed genes. Among 252 
them, 37 genes were also differentially expressed in islets from T2D individuals. 253 
Interestingly, this study identified changes in the DNA methylation pattern of multiple 254 
diabetes candidate genes, such as TCF7L2 and GLIS3 (74). These results suggest that 255 
lipid-induced epigenetic modifications may affect glucose-stimulated insulin secretion 256 
and/or β-cell survival by impacting on gene expression. 257 
In addition to the effect of the nutritional environment on metabolic health in the 258 
adulthood, numerous studies have attempted to elucidate the influence and the long-term 259 
consequences of a perturbed prenatal metabolic status. Maternal obesity and excessive 260 
caloric intake during pregnancy were found to expose the fetus to nutrient surfeit and to 261 
substantially increase the likelihood of an individual to become obese and develop 262 
metabolic disorders (75, 76). Indeed, the offspring of mothers fed a high fat diet (HFD) 263 
throughout pregnancy and lactation exhibits a remarkably similar obesogenic phenotype, 264 
characterized by increased fat mass, hyperinsulinemia, and hyperleptinemia (77). 265 
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Strikingly, these phenotypic traits are associated with the abnormal expression of 266 
regulatory genes in the pancreas of adult offspring including increased mRNA levels of 267 
INS1, INS2, proinflammatory cytokines (TNF-α, CD68 and IL1-R1), STAT3 and 268 
reduced expression of PI3K. These changes have been reported in the adult pancreas of 269 
offspring from mothers exposed to an obesogenic diet either pre-conception and 270 
throughout pregnancy and lactation, or merely during pregnancy and lactation periods 271 
(78). 272 
Protein-restricted diets during pregnancy have also a major impact on fetal 273 
pancreas and modifies the expression of more than 10% of the islet genes. The alterations 274 
concern mainly genes associated with the tricarboxylic acid cycle, ATP production, cell 275 
proliferation and anti-oxidative defense pathways and are prevented by maternal taurine 276 
supplementation throughout pregnancy (79). Epigenetic marks in the pancreatic genome 277 
of the offspring are believed to link the maternal diet to the susceptibility of developing 278 
obesity and diabetes, a phenomenon known as “cellular memory”. Indeed, maternal 279 
protein restriction elicited permanent modifications in histone marks in the enhancer 280 
region of the Hnf4a locus, resulting in the down-regulation of Hnf4a in the islets of the 281 
offspring (80). Impaired expression of this transcription factor can have a major impact 282 
on β-cell activities. Indeed, mutations in the Hnf4a gene result in the development of a 283 
particular form of diabetes (Maturity Onset Diabetes of the Young type 1) (81, 82). 284 
So far, most studies on the influence of the parental diet on metabolism and 285 
glucose homeostasis in the offspring have focused on the role of the mothers. 286 
Nonetheless, accumulating evidence suggest that the paternal diet has also an impact on 287 
the offspring metabolism. Morris and colleagues studied the transgenerational effect of 288 
paternal obesity and high fat feeding on rat progeny. Their study revealed that chronic 289 
exposure of male rats to HFD programs the dysfunction of β-cells in their female 290 
offspring causing the appearance of an early phenotype of glucose intolerance. The 291 
impaired glucose clearance worsens with aging and is associated with altered expression 292 
of 642 genes in the islets of adult female offspring (83). Gene ontology and KEGG 293 
pathway analysis highlighted an enrichment of dysregulated genes involved in insulin and 294 
glucose metabolism, as well as calcium-, MAPK- and Wnt-signaling, in the control of 295 
apoptosis and of the cell cycle. These transcriptomic changes were also accompanied by 296 
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epigenetic alterations such as hypomethylation of the Il13ra2 gene encoding for the 297 
Interleukin-13 receptor subunit alpha-2 (83). In a second survey, the same group 298 
extended this study by comparing the gene networks affected in retroperitoneal white 299 
adipose tissue and in pancreatic islets (84). Their analysis revealed that paternal diet-300 
induced obesity modifies the same cellular processes and signaling pathways in the fat 301 
tissue and in islets. In particular, they found that many genes encoding olfactory receptors 302 
are down-regulated in the progeny. These results suggest that paternal HFD exerts 303 
transgenerational regulation of the nutrient sensing machinery and causes impaired 304 
glucose homeostasis in F1 generation (84).  305 
Another study carried out in fruit flies reported that increased sugar in the diet of 306 
males for just 1 or 2 days before mating can lead to obesity in the next generation (85). 307 
High dietary sugar led to modifications in gene expression through epigenetic changes, 308 
without affecting growth and development in the progeny. Specifically, the 309 
transcriptomic profile of the offspring was characterized by an active deposition of the 310 
histones H3K9me3 and H3K27me3 and by changes in the expression of genes involved 311 
in key metabolic pathways, including glycolysis, Krebs cycle, mitochondrial metabolism 312 
and polysaccharide metabolism (85). These findings strengthen the conclusion that 313 
nutrient-induced transgenerational DNA methylation and their consequent modifications 314 
in gene expression can act as an endocrine disruptor and promote the development of 315 
impaired metabolic phenotypes.  316 
Overall, these studies carried out in mammals and flies highlight the role of non-317 
genetic factors in the transgenerational susceptibility to metabolic disorders. For an in 318 
depth description of the mechanisms through which the parental diet influences the 319 
metabolic phenotype in the offspring, we refer the reader to a recent review by Rando and 320 
Simons (86). 321 
322 
Impact of nutrients on non-coding RNA expression in β-cells 323 
The human genome contains about 21’000 protein-coding genes but the DNA sequences 324 
driving protein expression represent only about 2% of the 3.2 billion base pairs 325 
constituting our genome. Until recently, the sequences not involved in protein expression 326 
were considered evolutionary relic, irrelevant for the control of cellular activities. The 327 
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advent of new high-throughput sequencing techniques permitting a systematic analysis of 328 
all RNAs present in the cells has dramatically changed this view. Indeed, the results of 329 
the ENCODE (Encyclopedia of DNA Elements) project, an initiative launched in 2003 to 330 
identify all functional elements in the human genome, revealed that most DNA sequences 331 
can be transcribed to RNA giving rise to thousands of RNA molecules that are not 332 
translated to protein sequences (87, 88). These non-coding RNA transcripts fall in distinct 333 
categories according to their length and functional characteristics. Small non-coding 334 
RNAs that are shorter than 200 nucleotides include well described molecules such as 335 
transfer RNAs (tRNAs), small nucleolar RNAs (snoRNAs) and small nuclear RNAs 336 
(snRNAs) but also two large classes of newly discovered molecules, the Piwi-associated 337 
RNAs (piRNAs) and the microRNAs (miRNAs) (89, 90). PiRNAs are particularly 338 
abundant in the germline where they contribute to maintain genome integrity by 339 
preventing transposon movement (91, 92). MiRNAs are expressed in virtually all cells 340 
and are involved in a variety of physiological processes including cell differentiation, 341 
proliferation, apoptosis and in the development of many diseases, including cancer and 342 
diabetes (93-95). These non-coding small RNAs that are typically 21-23 nucleotide long 343 
are major regulators of gene expression. Each miRNA can partially pair to 3’untraslated 344 
regions of more than hundred different target mRNAs leading to translational repression 345 
and/or messenger degradation (96). The newly discovered long non-coding RNAs 346 
(lncRNAs) are longer than 200 nucleotides and can be involved in numerous gene 347 
regulatory activities such as transcription, splicing, protein degradation and chromatin 348 
modifications (97, 98).    349 
There is increasing evidence that non-coding RNAs actively contribute to the 350 
control of vital functions in the organism, including the maintenance of metabolic 351 
homeostasis. Indeed, many non-coding RNAs have been shown to be mis-expressed in 352 
human metabolic disorders. Among the different classes of non-coding RNAs, most 353 
studies focused on the role of miRNAs. Both glucose and lipids are able to regulate 354 
miRNA expression (Figure 2). Indeed, miR-34a and miR-146a expression is increased in 355 
response to prolonged exposure of the β-cell line MIN6 and pancreatic islets to palmitate 356 
(99). Altered levels of miR-34a were found to sensitize β-cells to apoptosis and to cause 357 
defective glucose-induced insulin secretion, whereas the rise in miR-146a promoted 358 
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stress-induced β-cell death (99). Another screen carried out in MIN6 cells led to the 359 
identification of 61 miRNAs regulated by glucose (100). Detailed analysis of the function 360 
of one of these miRNAs revealed that the increase of miR-30d occurring in the presence 361 
of elevated glucose concentrations induces the expression of the transcription factor 362 
MafA and, consequently, of the insulin gene (100, 101). In another in vitro study, primary 363 
islet cells and insulin-secreting cell lines incubated with stimulatory glucose 364 
concentrations displayed reduced levels of miR-375 (102), a key regulator of insulin 365 
production, insulin secretion and β-cell proliferation (103, 104). In contrast, prolonged 366 
exposure of human islets to high glucose concentrations caused the induction of miR-367 
133a, a miRNA targeting the mRNA of Polypirimidine Tract Binding protein (PTB) that 368 
is required for insulin mRNA stabilization (105). Blockade of miR-133a was able to 369 
prevent the decrease of PTB and in insulin biosynthesis rates observed upon chronic 370 
exposure to high-glucose, suggesting that this miRNA contributes to β-cell dysfunction 371 
under hyperglycemic conditions. Elevated glucose concentration was also found to up-372 
regulate miR-29a expression in human and rat islets, resulting in impaired glucose-373 
induced insulin release (106). The increase of miR-29 leads to direct translational 374 
repression of the plasma membrane monocarboxylate transporter, preventing the leakage 375 
of glycolytic intermediates out of the oxidative pathway and the entry of pyruvate-lactate 376 
in β-cells during exercise (107).  377 
Beside these studies carried out in vitro, several research teams investigated the impact of 378 
nutrients on β-cells in animal models. Global profiling of islets isolated from Goto-379 
Kakizaki rats, an animal model characterized by chronic hyperglycemia led to the 380 
identification of 30 differentially expressed miRNAs in pancreatic islets (108). The level 381 
of at least four of them, miR-130a, miR-132, miR-212 and miR-335 was found to be 382 
directly regulated by glucose. The miRNA expression profile is also strongly influenced 383 
by the diet. Indeed, mice maintained on a HFD for several weeks display major changes 384 
in islet miRNA expression (109, 110). Detailed analysis of the functional role of these 385 
miRNAs revealed that part of the changes elicited by the HFD have a positive impact on 386 
β-cells and result in the expansion of the β-cell mass and in improved insulin secretion 387 
(109). In fact, up-regulation of miR-132 increases the secretory capacity of β-cells, 388 
induces a higher proliferation rate and causes better survival in the presence of apoptotic 389 
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stimuli (109). The islets of mice on a HFD express also lower levels of miR-184 (109, 390 
110). Down-regulation of this miRNA promotes the proliferation of β-cells and protects 391 
them from palmitate-induced apoptosis (109, 110). Moreover, HFD causes a decrease in 392 
the expression of miR-338-3p (109), a miRNA that is also down-regulated during 393 
compensatory β-cell mass expansion in pregnant rats (111). Blockade of this miRNA 394 
using antisense oligonucleotides or with a viral construct capable of sequestering this 395 
non-coding RNA results in β-cell proliferation both in vitro and in vivo (111, 112). Taken 396 
together, these findings suggest that the changes in the level of these miRNAs are part of 397 
the mechanisms that allow β-cells to adapt to the rise in the insulin demand occurring 398 
under conditions of obesity and insulin resistance. However, not all changes in islet 399 
miRNA expression elicited in response to HFD are beneficial for the activity of insulin-400 
secreting cells. In fact, part of them have a deleterious impact on β-cell functions and may 401 
contribute to β-cell failure and to the development of diabetes. Indeed, down-regulation 402 
of miR-203, miR-210 and miR-383 resulted in an increase in apoptosis both in rat and 403 
human β-cells (109).  404 
Altered expression of miR‐7a, miR‐187 and a cluster of miRNAs in an imprinted 405 
locus on human chromosome 14q32 in islets from diabetic donors have also been 406 
reported and are associated with impaired insulin secretion and β‐cell dysfunction (113, 407 
114) (115). Moreover, the expression of several miRNAs was also modified in the islets 408 
of ob/ob and db/db obese mice that are deficient in leptin or in leptin receptor, 409 
respectively (104, 109, 116, 117). Although the precise mechanisms regulating the 410 
expression of most of these miRNAs is not yet known, at least part of the changes in the 411 
level of these non-coding RNAs is likely to be caused by the elevated plasma 412 
concentrations of triglycerides and free fatty acids observed in these obese animals. 413 
The level of several pancreatic miRNAs was also found to be altered in rats born 414 
from mothers fed a low-protein diet during pregnancy (118). In particular, prenatal 415 
protein restriction resulted in the overexpression of miR-375 in the fetuses. The level of 416 
this miRNA remained augmented in the islets of adult rats, likely contributing to the 417 
reduced β-cell mass and function typically observed in the progeny of mothers fed a low-418 
protein diet.   419 
Oligonutrients can also regulate the expression of miRNAs within the endocrine 420 
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pancreas. Grape seed procyanidin extracts (GSPE) have been demonstrated to directly act 421 
on islet cells and to modulate insulin production by down-regulating insulin gene 422 
expression as well as insulin exocytosis-related genes and by inhibiting insulin 423 
biosynthesis (119). The miRNA expression profile of rat islets exposed to GSPE for 45 424 
days revealed a significant down-regulation of miR-1249, miR-483, miR-30c-1*, and up-425 
regulation miR-3544. Gene Ontology analysis of the predicted targets of these miRNAs, 426 
revealed an enrichment of genes coding for components of the insulin-signaling pathway 427 
such as AKT and ERK, suggesting that procyanidins exert their bioactivity on pancreatic 428 
islets by modifying the expression of a group of miRNAs (119).  429 
LncRNAs have emerged as a novel class of functional RNAs and are strongly 430 
suspected to regulate genome activities through a broad spectrum of mechanisms (98, 431 
120, 121). Pioneering studies by Ferrer and colleagues led to the identification of 432 
numerous conserved β-cell specific lncRNAs that are dysregulated in islets of 433 
hyperglycemic T2D donors and often mapping to genomic regions enriched in islet 434 
protein-coding genes (122). A very elegant genetic screening of 89 human pancreatic islet 435 
samples has recently unveiled numerous genetic variants including many lncRNAs 436 
suggested to regulate gene expression and exon use. Among the coding-genes and the 437 
493 lncRNAs detected in islet cells, multiple SNPs were associated to known T2D-438 
associated genes differing according to the normoglycemic or hyperglycemic status of the 439 
patients (123).  440 
The imprinted lncRNA H19 that is generated from the Igf2 locus has been 441 
involved in the transgenerational transmission of epigenetic changes in germ cells in a 442 
mouse model of gestational diabetes mellitus (124). This study unveiled that intrauterine 443 
hyperglycemia alters the methylation of the gene and reduces the expression of Igf2/H19 444 
in the islets of Langerhans. Igf2 and H19 expression was also altered in the sperm of 445 
adult progeny from hyperglycemic mothers, indicating that epigenetic changes in germ 446 
cells contribute to transgenerational transmission of metabolic disorders (124). 447 
448 
Conclusion 449 
Pancreatic β-cells and insulin, their main secretory product, are at the core of a complex 450 
regulatory network that governs body metabolism and energy expenditure. 451 
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Carbohydrates, lipids and proteins are all capable of generating signals inside β-cells 452 
eliciting immediate insulin release or engendering changes in the expression of protein-453 
coding and non-coding RNAs that allow the β-cells to adapt their activities to conditions 454 
of increased insulin demand. The excess of dietary nutrients within critical developmental 455 
windows or in the adulthood can, however, have deleterious consequences on β-cell 456 
functions, causing metabolic perturbations and the manifestation of different forms of 457 
diabetes mellitus. Therefore, a better understanding of the events elicited by dietary 458 
nutrients in β-cells will be of paramount importance for the design of new therapeutic 459 
approaches to prevent and treat these metabolic disorders that are reaching epidemic 460 
proportions.  461 
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Legends 831 
832 
Table 1: Gut-derived peptides and peptide hormones in the gastrointestinal tract 833 
834 
Figure 1: Regulators of insulin secretion through nutrient, hormonal and neural 835 
signals. The figure summarizes the different molecules contributing to the fine-tuning of 836 
insulin secretion-  837 
838 
Figure 2: Glucose and fatty acids modify function and mass of β-cells by altering 839 
miRNA levels. Expression of several miRNAs is up- or down-regulated (up and down 840 
arrows) upon exposure to glucose or fatty acids. Glucose regulates the expression of miR-841 
29a, miR-30d, miR-133a, and miR-375. Fatty acids (palmitate or a high-fat diet) regulate 842 
the expression of miR-34a, miR-132, miR-146a, miR-184, miR-203, miR-210, miR-338-843 
3p, and miR-383. MiRNAs in green have a positive effect on insulin synthesis and 844 
secretion, proliferation and survival, while those in red have a negative effect. MiRNAs 845 
marked with a blue square are implicated in two or more cellular processes. 846 
847 
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Families	  and	  members	   Main	  regulatory	  ac4vity	  
Secre%n	  family	  
Secre%n	  	   é	  pancrea%c	  bicarbonate	  secre%on	  
Glucagon-­‐like	  pep%de	  1	  (GLP1)	   é	  insulin	  secre%on	  
ê	  glucagon	  secre%on	  
ê	  gastric	  emptying	  	  
Glucagon-­‐like	  pep%de	  2	  (GLP2)	   é	  mucosal	  cell	  growth	  
Gastric	  inhibitory	  polypep%de	  (GIP)	   é	  insulin	  secre%on	  
ê	  gastric	  emptying	  
Vasoac%ve	  intes%nal	  polypep%de	  (VIP)	   ê  gastrointes%nal	  mo%lity	  
é	  ﬂuid	  secre%on	  
Gastrin	  family	  
Gastrin	   é	  mucosal	  cell	  growth	  
é	  gastric	  secre%on	  
Cholecystokinin	  (CCK)	   é	  pancrea%c	  enzyme	  secre%on	  
é	  cell	  growth	  
é	  gall-­‐bladder	  emptying	  
ê	  gastric	  acid	  secre%on	  
Tachykinin	  family	  
Susbtance	  P	   é	  mo%lity	  
Neurokinin	  A	   é	  mo%lity	  
Neurokinin	  B	   é	  mo%lity	  
Ghrelin	  family	  
Ghrelin	   é  Appe%te	  
Mo%lin	   é	  mo%lity	  
Obesta%n	  	   Involved	  in	  food	  intake	  
PP-­‐fold	  family	  
Neuropep%de	  Y	  (NPY)	   é	  contrac%lity	  
Pep%de	  YY	  (PYY)	   ê  gastric	  emptying	  
ê  pancrea%c	  exocrine	  secre%on	  
Singular	  pep%de	  hormones	  
Somatosta%n	   ê  gastric	  secre%on	  
ê  pancrea%c	  endocrine	  secre%on	  
Neurotensin	   é  contrac%lity	  
é  gut	  secre%on	  
Galanin	   é  mo%lity	  
é  gut	  secre%on	  
Table	  1.	  Gut-­‐derived	  pep4des	  and	  pep4de	  hormones	  in	  the	  
gastrointes4nal	  tract	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AdrenalineAcetylcholine
Gq Gi
Glucose
GlutGq
Gs
GLP-1, GIP, 
VIP, PYY,
Estradiol
Hormonal 
signals
Nutrient signals
Neural signals
Leptin, EGF, 
Insulin/IGF1, 
PRL, PL, GH
T1R2/3
Insulin processing 
and release
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Gq
apoptosis
Pancreatic β-cell
insulin synthesis and secretion
miR-29a
miR-30d
miR-34a
proliferation
miR-132
miR-184
miR-338-3p
miR-375
miR-132
miR-133a
miR-375
miR-34a
miR-132
miR-146a
miR-184
miR-203
miR-210
miR-383
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